|
Gianpiero Celino is a director
at Webstar Health, which provides consulting and project-management
support to PCTs
and contractors
David Reissner is a partner and head of healthcare
at Charles Russell LLP |
Control of entry
Normally, anyone wishing to provide NHS services
from a new pharmacy must satisfy a restrictive test of necessity
or desirability in
order to secure adequate pharmaceutical services.
The NHS (Pharmaceutical
Services) Regulations 2005 introduced exemptions to this test
for four types of application, the most common of these from pharmacies
open at least 100 hours a week. There are few ways in which applications
for these kinds of contracts can be rejected.
However, PCTs cannot
grant applications that would otherwise be exempt from the
necessary or desirable test if there is, or will be, LPS in the
neighbourhood. |
SUMMARY
Until 2003, community pharmacy owners could only provide NHS services
under a national (PhS) contract. The local pharmaceutical services (LPS)
scheme was introduced in 2003 as a means to test new ways of working
in community pharmacy. Initially a pilot programme, LPS arrangements
were made permanent through regulations laid before Parliament in April
2005.
After an initial flurry of activity, interest in LPS declined, but the
concept remains a tool in the armoury for those seeking to innovate in
the provision of pharmaceutical services. Recently, interest in LPS has
been renewed due to the protection that it offers contractors from the
threat of 100-hour pharmacy applications.
In the absence of guidance from the Department of Health (DoH), contractors
and primary care trusts may find regulations relating to the LPS scheme
cumbersome and complex. This article attempts to answer questions that
have been raised by PCTs and contractors grappling with the LPS framework
to allow them to develop their plans.
Full text article (PDF 40K) |